Eurofins Scientific: Director / PDMR Shareholding

This notification is made in accordance with the European Market Abuse Regulation.

NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM

 

 

1.

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

Analytical Bioventures S.C.A (RCS B89265)
23, Va Fleuri, L-1526 Luxembourg

2.

Reason for the notification

a)

Position / status

Analytical Bioventures S.C.A. is a company controlled by Eurofins Scientific S.E., CEO Dr. Gilles Martin

b)

Initial notification / amendment

Initial

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Eurofins Scientific S.E.

 

b)

LEI

529900JEHFM47DYY3S57

 

4.

Details of the transaction(s) section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Share

 

Identification code

ISIN: FR0014000MR3

b)

Nature of the transaction

Acquisition of shares

 

 

c)

Price(s) and volume(s)

Price(s)

Volume(s)

EUR 59.99790

1000

d)

Aggregated information

 

— Aggregated volume

1000

— Price

EUR 59,997.90

e)

Date of the transaction

2025-07-14

f)

Place of the transaction

XPAR

NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM

 

 

1.

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

Analytical Bioventures S.C.A (RCS B89265)
23, Va Fleuri, L-1526 Luxembourg

2.

Reason for the notification

a)

Position / status

Analytical Bioventures S.C.A. is a company controlled by Eurofins Scientific S.E., CEO Dr. Gilles Martin

b)

Initial notification / amendment

Initial

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Eurofins Scientific S.E.

 

b)

LEI

529900JEHFM47DYY3S57

 

4.

Details of the transaction(s) section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Share

 

Identification code

ISIN: FR0014000MR3

b)

Nature of the transaction

Acquisition of shares

 

 

c)

Price(s) and volume(s)

Price(s)

Volume(s)

EUR 59.90000

53

d)

Aggregated information

 

— Aggregated volume

53

— Price

EUR 3,174.70

e)

Date of the transaction

2025-07-15

f)

Place of the transaction

XPAR

NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM

About Eurofins – the global leader in bio-analysis

Eurofins is Testing for Life. With ca. 63,000 staff across a network of more than 950 laboratories in over 1,000 companies in 60 countries, Eurofins offers a portfolio of over 200,000 analytical methods.

Eurofins Scientific S.E. shares are listed on Euronext Paris Stock Exchange.

View source version on businesswire.com: https://www.businesswire.com/news/home/20250718393743/en/

@ businesswire.com

Hol dir den Wissensvorsprung der Profis. Seit 2005 liefert der Börsenbrief trading-notes verlässliche Trading-Empfehlungen – dreimal die Woche, direkt in dein Postfach. 100% kostenlos. 100% Expertenwissen. Trage einfach deine E-Mail Adresse ein und verpasse ab heute keine Top-Chance mehr.
Jetzt anmelden.